The World Drug Safety Congress Europe was an incredible experience!
On Wednesday, October 9, 2024, at 12:05 PM, our CEO, Martin Holm-Petersen, spoke at the PV Outsourcing session (G109) about “Future-proofing Pharmacovigilance: Governance, Data Collection, and Analyses for Global Success.” Then, on Thursday, October 10, at 12:05 PM, he presented on “The Roadmap for PV Innovation: The Future of Technology-Led PV Innovation from Now Towards 2030” in the Artificial Intelligence Auditorium.
Our team—comprised of Martin Holm-Petersen (CEO), Jen Markey (Chief Sales and Marketing Officer), Louise Tan (Global Head of Regulatory Intelligence), Malin Kreitz (Business Development Director), Tina Fumić (Sales and Marketing Manager), and Nataša Belakon (Sales and Marketing Consultant)—was on-site representing Insife and showcasing our industry-leading pharmacovigilance platform, HALOPV. Attendees had the opportunity to meet us at Booth 39, where we offered live demos of HALOPV, designed to streamline and enhance pharmacovigilance processes. HALOPV continues to set new standards in the industry by providing innovative solutions for regulatory compliance and drug safety management.
A heartfelt thank you to everyone who visited us at Booth 39 during WDSC EU 2024!
We’re excited about the future of pharmacovigilance, and we look forward to continuing the conversation. Let’s explore how HALOPV can drive innovation in your safety operations. A special thanks to the WDSC for organizing such a fantastic event—it gets better every year! And thank you to RAI Amsterdam for hosting us. See you next time!